{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:23:57Z","timestamp":1791973437229,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Skeletal muscle can be directly affected by systemic sclerosis (SSc); however, a significant burden of SSc-associated myopathy is undetected because clinical parameters such as weakness and creatine kinase (CK) are unreliable biomarkers of muscle involvement. This study presents qualitative and quantitative magnetic resonance imaging (MRI) findings that quantify the prevalence of myopathy and evaluate any association between skeletal and cardiac muscle involvement in SSc.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-two patients with SSc who fulfilled the 2013 American College of Rheumatology\/European League Against Rheumatism classification criteria underwent skeletal muscle MRI in addition to cardiac MRI. Skeletal muscles were independently assessed by two musculoskeletal radiologists for evidence of oedema, fatty infiltration and atrophy. Skeletal muscle T2 mapping times and percentage fat fraction were calculated. Linear regression analysis was used to evaluate the clinical and myocardial associations with skeletal muscle oedema and fatty infiltration. Cardiac MRI was performed using post gadolinium contrast imaging and parametric mapping techniques to assess focal and diffuse myocardial fibrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirteen participants (40.6%) had MRI evidence of skeletal muscle oedema. Five (15.6%) participants had fatty infiltration. There was no association between skeletal muscle oedema and muscle strength, creatine kinase, inflammatory markers or fibroinflammatory myocardial disease. Patients with skeletal muscle oedema had higher T2-mapping times; there was a significant association between subjective assessments of muscle oedema and T2-mapping time (coef 2.46, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and percentage fat fraction (coef 3.41, <jats:italic>p<\/jats:italic>\u2009=\u20090.02). Diffuse myocardial fibrosis was a near-universal finding, and one third of patients had focal myocardial fibrosis. There was no association between skeletal myopathy detected by MRI and burden of myocardial disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MRI is a sensitive measure of muscle oedema and systematic assessment of SSc patients using MRI shows that myopathy is highly prevalent, even in patients without symptoms or other signs of muscle involvement. Similarly, cardiac fibrosis is highly prevalent but occurs independently of skeletal muscle changes. These results indicate that novel quantitative MRI techniques may be useful for assessing sub-clinical skeletal muscle disease in SSc.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02768-z","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T07:04:09Z","timestamp":1649660649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Laura","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniina","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Pianta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"La Gerche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"issue":"10103","key":"2768_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685\u201399.","journal-title":"Lancet"},{"issue":"6","key":"2768_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/BOR.0000000000000336","volume":"28","author":"JJ Paik","year":"2016","unstructured":"Paik JJ. Myopathy in scleroderma and in other connective tissue diseases. Curr Opin Rheumatol. 2016;28(6):631\u20135.","journal-title":"Curr Opin Rheumatol"},{"issue":"suppl_5","key":"2768_CR3","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/rheumatology\/kex196","volume":"56","author":"UA Walker","year":"2017","unstructured":"Walker UA, Clements PJ, Allanore Y, Distler O, Oddis CV, Khanna D, et al. Muscle involvement in systemic sclerosis: points to consider in clinical trials. Rheumatology (Oxford). 2017;56(suppl_5):v38\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"2768_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102851","volume":"20","author":"F Lefebvre","year":"2021","unstructured":"Lefebvre F, Giannini M, Ellezam B, Leclair V, Troyanov Y, Hoa S, et al. Histopathological features of systemic sclerosis-associated myopathy: a scoping review. Autoimmun Rev. 2021;20(7):102851.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2768_CR5","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/acr.22620","volume":"67","author":"JJ Paik","year":"2015","unstructured":"Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola-Rosen L, Shah AA, et al. Spectrum of muscle histopathologic findings in forty-two scleroderma patients with weakness. Arthritis Care Res (Hoboken). 2015;67(10):1416\u201325.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"2768_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/03009742.2013.868512","volume":"43","author":"M Jung","year":"2014","unstructured":"Jung M, Bonner A, Hudson M, Baron M, Pope JE. Canadian Scleroderma Research Group: Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort. Scand J Rheumatol. 2014;43(3):217\u201320.","journal-title":"Scand J Rheumatol"},{"key":"2768_CR7","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/ar4562","volume":"16","author":"K Bhansing","year":"2014","unstructured":"Bhansing K, Lammens M, Knaapen HKA, van Riel PL, van Engelen BG, Vonk M. Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clincal features and myopathology. Arthritis Res Ther. 2014;16:R111.","journal-title":"Arthritis Res Ther"},{"issue":"33","key":"2768_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021734","volume":"99","author":"M Zhou","year":"2020","unstructured":"Zhou M, Jiang L, Nie L, Chen T, Zhang T, Sun W, et al. Myopathy is a risk factor for poor prognosis of patients with systemic sclerosis: a retrospective cohort study. Medicine (Baltimore). 2020;99(33):e21734.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"2768_CR9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/ard.2008.095919","volume":"68","author":"B Ranque","year":"2009","unstructured":"Ranque B, Authier FJ, Le-Guern V, Pagnoux C, Berezne A, Allanore Y, et al. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis. 2009;68(9):1474\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2768_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","volume":"125","author":"WP Follansbee","year":"1993","unstructured":"Follansbee WP, Zerbe TR, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J. 1993;125(1):194\u2013203.","journal-title":"Am Heart J"},{"issue":"2","key":"2768_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10067-004-0975-7","volume":"24","author":"Y Mimura","year":"2005","unstructured":"Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol. 2005;24(2):99\u2013102.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2768_CR12","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/acr.23291","volume":"69","author":"JJ Paik","year":"2017","unstructured":"Paik JJ, Wigley FM, Shah AA, Corse AM, Casciola-Rosen L, Hummers LK, et al. Association of fibrosing myopathy in systemic sclerosis and higher mortality. Arthritis Care Res (Hoboken). 2017;69(11):1764\u201370.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"2768_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.semarthrit.2018.07.008","volume":"48","author":"L Ross","year":"2019","unstructured":"Ross L, Prior D, Proudman S, Vacca A, Baron M, Nikpour M. Defining primary systemic sclerosis heart involvement: a scoping literature review. Semin Arthritis Rheum. 2019;48(5):874\u201387.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2768_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00330-012-2584-1","volume":"23","author":"S Schanz","year":"2013","unstructured":"Schanz S, Henes J, Ulmer A, Kotter I, Fierlbeck G, Claussen CD, et al. Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. Eur Radiol. 2013;23(1):212\u201321.","journal-title":"Eur Radiol"},{"issue":"6","key":"2768_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/BOR.0000000000000549","volume":"30","author":"A Oldroyd","year":"2018","unstructured":"Oldroyd A, Chinoy H. Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2018;30(6):606\u201313.","journal-title":"Curr Opin Rheumatol"},{"key":"2768_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.semarthrit.2016.11.001","volume":"46","author":"J Day","year":"2017","unstructured":"Day J, Patel B, Limaye V. The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies. Semin Arthritis Rheum. 2017;46:642\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2768_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/mus.25099","volume":"54","author":"S Barsotti","year":"2016","unstructured":"Barsotti S, Zampa V, Talarico R, Minichilli F, Ortori S, Iacopetti V, et al. Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center. Muscle Nerve. 2016;54(4):666\u201372.","journal-title":"Muscle Nerve"},{"issue":"11","key":"2768_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-015-0544-x","volume":"17","author":"B Maurer","year":"2015","unstructured":"Maurer B, Walker UA. Role of MRI in diagnosis and management of idiopathic inflammatory myopathies. Curr Rheumatol Rep. 2015;17(11):67.","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"2768_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mus.26660","volume":"60","author":"JA Day","year":"2019","unstructured":"Day JA, Bajic N, Gentili S, Patel S, Limaye V. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies. Muscle Nerve. 2019;60(5):549\u201357.","journal-title":"Muscle Nerve"},{"issue":"6","key":"2768_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","volume":"73","author":"C Malattia","year":"2014","unstructured":"Malattia C, Damasio MB, Madeo A, Pistorio A, Providenti A, Pederzoli S, et al. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis. 2014;73(6):1083\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2768_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14737175.2019.1572507","volume":"19","author":"S Paramalingam","year":"2019","unstructured":"Paramalingam S, Counsel P, Mastaglia FL, Keen H, Needham M. Imaging in the diagnosis of idiopathic inflammatory myopathies; indications and utility. Expert Rev Neurother. 2019;19(2):173\u201384.","journal-title":"Expert Rev Neurother"},{"issue":"7-8","key":"2768_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0960-8966(02)00023-8","volume":"12","author":"E Mercuri","year":"2002","unstructured":"Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, Counsell S, et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord. 2002;12(7-8):631\u20138.","journal-title":"Neuromuscul Disord"},{"key":"2768_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/01.wnl.0000324927.28817.9b","volume":"71","author":"D Fischer","year":"2008","unstructured":"Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K, et al. Distrinct muscle imaging patterns in myofibrillar myopathies. Neurology. 2008;71:758\u201365.","journal-title":"Neurology"},{"issue":"6","key":"2768_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00415-006-0111-5","volume":"253","author":"C Kornblum","year":"2006","unstructured":"Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schroder R, et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study. J Neurol. 2006;253(6):753\u201361.","journal-title":"J Neurol"},{"key":"2768_CR25","first-page":"441","volume":"55","author":"L Yao","year":"2016","unstructured":"Yao L, Yip AL, Shrader JA, Mesdaghinia S, Volochayev R, Jansen AV, et al. Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies. Rheumatology (Oxford). 2016;55:441\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2768_CR26","doi-asserted-by":"publisher","first-page":"81 e81","DOI":"10.1016\/j.crad.2020.08.022","volume":"76","author":"M Farrow","year":"2021","unstructured":"Farrow M, Biglands JD, Grainger AJ, O'Connor P, Hensor EMA, Ladas A, et al. Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessment. Clin Radiol. 2021;76(1):81 e81\u201310.","journal-title":"Clin Radiol"},{"issue":"6","key":"2768_CR27","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.acra.2020.04.022","volume":"28","author":"J Ran","year":"2021","unstructured":"Ran J, Yin C, Liu C, Li Y, Hou B, Morelli JN, et al. The diagnostic value of MR IVIM and T2 mapping in differentiating autoimmune myositis from muscular dystrophy. Acad Radiol. 2021;28(6):e182\u20138.","journal-title":"Acad Radiol"},{"issue":"11","key":"2768_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2768_CR29","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (Systemic Sclerosis): classification, subsets & pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"issue":"10","key":"2768_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s10554-017-1134-y","volume":"33","author":"BT Costello","year":"2017","unstructured":"Costello BT, Springer F, Hare JL, La Gerche A, Iles L, Ellims AH, et al. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T. Int J Cardiovasc Imaging. 2017;33(10):1551\u201360.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"5","key":"2768_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11547-020-01317-5","volume":"126","author":"S Ahlawat","year":"2021","unstructured":"Ahlawat S, Paik J, Del Grande F, Paris ES, Sujlana P, Fayad LM. Distinct MR features in scleroderma associated myopathy. Radiol Med. 2021;126(5):707\u201316.","journal-title":"Radiol Med"},{"issue":"2","key":"2768_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1590\/bjpt-rbf.2014.0084","volume":"19","author":"TR Lima","year":"2015","unstructured":"Lima TR, Guimaraes FS, Carvalho MN, Sousa TL, Menezes SL, Lopes AJ. Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis. Braz J Phys Ther. 2015;19(2):129\u201336.","journal-title":"Braz J Phys Ther"},{"issue":"3","key":"2768_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.rdc.2015.04.011","volume":"41","author":"KB Morrisroe","year":"2015","unstructured":"Morrisroe KB, Nikpour M, Proudman SM. Musculoskeletal manifestations of systemic sclerosis. Rheum Dis Clin North Am. 2015;41(3):507\u201318.","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"2768_CR34","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/rheumatology\/kes206","volume":"51","author":"D Harel","year":"2012","unstructured":"Harel D, Thombs BD, Hudson M, Baron M, Steele R. Canadian Scleroderma Research Group: Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale. Rheumatology (Oxford). 2012;51(12):2177\u201385.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2768_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/acr.24122","volume":"73","author":"SL Murphy","year":"2021","unstructured":"Murphy SL, Kratz AL, Whibley D, Poole JL, Khanna D. Fatigue and its association with social participation, functioning, and quality of life in systemic sclerosis. Arthritis Care Res (Hoboken). 2021;73(3):415\u201322.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"2768_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13317-014-0063-1","volume":"5","author":"L Iaccarino","year":"2014","unstructured":"Iaccarino L, Pegoraro E, Bello L, Bettio S, Borella E, Nalotto L, et al. Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation. Auto Immun Highlights. 2014;5(3):87\u201394.","journal-title":"Auto Immun Highlights"},{"issue":"6","key":"2768_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/BOR.0000000000000745","volume":"32","author":"N Pipitone","year":"2020","unstructured":"Pipitone N, Salvarani C. Up-to-date treatment and management of myositis. Curr Opin Rheumatol. 2020;32(6):523\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"2768_CR38","doi-asserted-by":"crossref","unstructured":"Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, et al. Treatment in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).\u00a0Ann Rheum Dis. 2017;76(7):1207\u201318.","DOI":"10.1136\/annrheumdis-2016-210503"},{"issue":"3","key":"2768_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","volume":"57","author":"VK Jaeger","year":"2018","unstructured":"Jaeger VK, Distler O, Maurer B, Czirjak L, Lorand V, Valentini G, et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018;57(3):441\u201350.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02768-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T07:12:34Z","timestamp":1649661154000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02768-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by St Vincent\u2019s Hospital, Melbourne Human Research Ethics Committee (HREC 181\/18), and the study was performed in accordance with the Declaration of Helsinki. All patients gave written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent was provided for publication of magnetic resonance imaging.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MN receives research support from Actelion, Astra Zeneca, BMS, GSK, Janssen and UCB and has received honoraria from Actelion, Boehringer Ingelheim, Eli Lilly, GSK, Janssen, Pfizer and UCB. All other study authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}